TherapeuticsMD
TXMD
TXMD
123 hedge funds and large institutions have $1.36B invested in TherapeuticsMD in 2016 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 51 increasing their positions, 31 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
123
Holders Change
-5
Holders Change %
-3.91%
% of All Funds
3.29%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.03%
New
15
Increased
51
Reduced
31
Closed
18
Calls
$4.97M
Puts
$1.14M
Net Calls
+$3.82M
Net Calls Change
+$2.18M
Top Buyers
| 1 |
JPMorgan Chase & Co
New York
|
+$28.1M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$25.5M |
| 3 |
Bank of New York Mellon
New York
|
+$25.1M |
| 4 |
Franklin Resources
San Mateo,
California
|
+$10.6M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$6.3M |
Top Sellers
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$27M |
| 2 |
Millennium Management
New York
|
-$6.34M |
| 3 |
State Street
Boston,
Massachusetts
|
-$3.8M |
| 4 |
GH
GAM Holding
Zurich,
Switzerland
|
-$3.7M |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$1.55M |
